Company intelligence / Profile preview

Nicast

Lod, Israel

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Nicast is a medical device company specializing in the development and manufacture of implantable medical devices using proprietary electrospinning technology. The company's platform produces nanofiber-based scaffolds from various polymers, mimicking the structure of the natural extracellular matrix to promote tissue regeneration and integration. Its lead commercial product, NovaGraft, is an artificial vascular graft designed for patients undergoing hemodialysis. Nicast also applies its electrospinning expertise to other clinical areas, including hernia repair meshes and advanced wound care dressings.

Therapeutic areas: CardiovascularDermatologyGastroenterology
Modalities: DeviceNanoparticlePolymer-based scaffold
Industry: Implantable Medical Devices

Partnerships

Atrium Medical Corporation

Beyond the preview

Go deeper on Nicast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicast.

Explore the full profile